Company · CIK 0001099800 · SIC 3842 — Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE
Edwards Lifesciences Corp · EW
Insider activity reported against this company. All insider holders · Files at: CASM. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2026 FForm 4 → | Sep 14, 6:04 pm EDT | Andrew M. DahlSVP, Corporate Controller | 253 | $84.37 | $21,346 | 14,615 | — | |
| Sep 11, 2026 FForm 4 → | Sep 14, 6:04 pm EDT | Wayne MarkowitzCVP, JAPAC | 923 | $85.29 | $78,726 | 19,371 | — | |
| Sep 11, 2026 FForm 4 → | Sep 11, 7:15 pm EDT | Daveen ChopraCVP, TMTT, Surgical & IHFM | 398 | $86.77 | $34,534 | 43,926 | — | |
| Sep 11, 2026 SForm 4 → | Sep 11, 7:15 pm EDT | Daniel J. LippisCVP, TAVR | 619 | $87.51 | $54,169 | 40,034 | −1.52% | 10b5-1 |
| Sep 11, 2026 MForm 4 → | Sep 11, 7:15 pm EDT | Daniel J. LippisCVP, TAVR | 619 | $72.68 | $44,989 | 40,653 | — | 10b5-1 |
| Aug 31, 2026 SForm 4 → | Aug 31, 5:47 pm EDT | Andrew M. DahlSVP, Corporate Controller | 544 | $91.06 | $49,534 | 14,868 | −3.53% | |
| Aug 28, 2026 SForm 4 → | Aug 28, 4:32 pm EDT | Annette BrulsCVP, EMEACLA | 2,644 | $89.98 | $237,907 | 17,984 | −12.8% | |
| Aug 26, 2026 SForm 4 → | Aug 26, 6:36 pm EDT | Daveen ChopraCVP, TMTT, Surgical & IHFM | 31,800 | $91.02 | $2,894,440 | 44,324 | −41.8% | |
| Aug 26, 2026 MForm 4 → | Aug 26, 6:36 pm EDT | Daveen ChopraCVP, TMTT, Surgical & IHFM | 31,800 | $72.68 | $2,311,224 | 76,124 | — | |
| Aug 26, 2026 SForm 4 → | Aug 26, 6:00 pm EDT | Wayne MarkowitzCVP, JAPAC | 1,240 | $91.47 | $113,417 | 20,294 | −5.76% | |
| Aug 11, 2026 SForm 4 → | Aug 11, 5:07 pm EDT | Daniel J. LippisCVP, TAVR | 619 | $92.03 | $56,967 | 40,034 | −1.52% | 10b5-1 |
| Aug 11, 2026 MForm 4 → | Aug 11, 5:07 pm EDT | Daniel J. LippisCVP, TAVR | 619 | $72.68 | $44,989 | 40,653 | — | 10b5-1 |
| Jul 30, 2026 SForm 4 → | Jul 30, 5:30 pm EDT | Wayne MarkowitzCVP, JAPAC | 146 | $86.03 | $12,588 | 21,534 | −0.67% | |
| Jul 28, 2026 SForm 4 → | Jul 28, 7:40 pm EDT | Wayne MarkowitzCVP, JAPAC | 9,628 | $85.06 | $818,958 | 21,680 | −30.8% | |
| Jul 28, 2026 MForm 4 → | Jul 28, 7:40 pm EDT | Wayne MarkowitzCVP, JAPAC | 9,628 | $74.02 | $712,665 | 31,308 | — | |
| Jul 27, 2026 SForm 4 → | Jul 27, 6:59 pm EDT | Bernard J ZovighianCEO, Director | 2,921 | $83.93 | $245,134 | 8,916 | −24.7% | |
| Jul 27, 2026 GForm 4 → | Jul 27, 6:59 pm EDT | Bernard J ZovighianCEO, Director | 639 | — | — | 11,836 | — | |
| Jul 11, 2026 FForm 4 → | Jul 13, 4:09 pm EDT | Annette BrulsCVP, EMEACLA | 109 | $92.21 | $10,051 | 20,628 | — | |
| Jul 10, 2026 SForm 4 → | Jul 10, 5:04 pm EDT | Daniel J. LippisCVP, TAVR | 619 | $91.70 | $56,762 | 40,034 | −1.52% | 10b5-1 |
| Jul 10, 2026 MForm 4 → | Jul 10, 5:04 pm EDT | Daniel J. LippisCVP, TAVR | 619 | $72.68 | $44,989 | 40,653 | — | 10b5-1 |
| Jul 9, 2026 AForm 4 → | Jul 10, 5:11 pm EDT | Theodora MistrasCVP, Chief Financial Officer | 99,920 | — | — | 99,920 | — | |
| Jul 7, 2026 FForm 4 → | Jul 7, 6:56 pm EDT | Daniel J. LippisCVP, TAVR | 377 | $95.18 | $35,883 | 40,034 | — | |
| Jun 30, 2026 SForm 4 → | Jun 30, 8:01 pm EDT | Daniel J. LippisCVP, TAVR | 619 | $91.40 | $56,577 | 40,411 | −1.51% | 10b5-1 |
| Jun 30, 2026 MForm 4 → | Jun 30, 8:01 pm EDT | Daniel J. LippisCVP, TAVR | 619 | $72.68 | $44,989 | 41,030 | — | 10b5-1 |
| Jun 17, 2026 SForm 4 → | Jun 17, 8:19 pm EDT | Bernard J ZovighianCEO, Director | 523 | $87.92 | $45,982 | 11,517 | −4.34% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 MForm 4 → | Sep 11, 7:15 pm EDT | Daniel J. LippisCVP, TAVR | 619 | — | — | 3,714 | — | 10b5-1 |
| Aug 26, 2026 MForm 4 → | Aug 26, 6:36 pm EDT | Daveen ChopraCVP, TMTT, Surgical & IHFM | 31,800 | — | — | 0 | — | |
| Aug 11, 2026 MForm 4 → | Aug 11, 5:07 pm EDT | Daniel J. LippisCVP, TAVR | 619 | — | — | 4,333 | — | 10b5-1 |
| Jul 28, 2026 MForm 4 → | Jul 28, 7:40 pm EDT | Wayne MarkowitzCVP, JAPAC | 9,628 | — | — | 9,628 | — | |
| Jul 10, 2026 MForm 4 → | Jul 10, 5:04 pm EDT | Daniel J. LippisCVP, TAVR | 619 | — | — | 4,952 | — | 10b5-1 |
| Jul 9, 2026 AForm 4 → | Jul 10, 5:11 pm EDT | Theodora MistrasCVP, Chief Financial Officer | 74,125 | — | — | 12,325 | — | |
| Jun 30, 2026 MForm 4 → | Jun 30, 8:01 pm EDT | Daniel J. LippisCVP, TAVR | 619 | — | — | 5,571 | — | 10b5-1 |
Filed by this entity as an insider elsewhere — common stock
No reported common-stock activity in this period.
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.